Arie Perry

79.0k citations
384 papers · 41.0k · 9 hit papers · h-index 85

Impact in

  • Genetics top 0.01%
    • Glioma Diagnosis and Treatment
  • Neurology top 0.02%
    • Neurofibromatosis and Schwannoma Cases
    • Neuroblastoma Research and Treatments

Papers in

    • Glioma Diagnosis and Treatment 175
    • Neurofibromatosis and Schwannoma Cases 93
    • Neuroblastoma Research and Treatments 49
    • Vascular Malformations Diagnosis and Treatment 18

Arie Perry

368 papers receiving 40.5k citations

Arie Perry's Hit Papers

Overview of the 2022 WHO Classification of Pituitary Tumors 2022 · 314 citations
3140+8+17Years since publication2.5k5.0k7.5k10.0k

Peers

Arie Perry
Comparison fields: 5 of 171
  • Genetics 18.5k
  • Neurology 8.5k
  • Cancer Research 5.3k
  • Epidemiology 8.3k
  • Pulmonary and Respiratory Medicine 5.5k
Replace Peter C. Burger with:
Peter C. Burger United States
Otmar D. Wiestler Germany
Andreas von Deimling Germany
Bernd W. Scheithauer United States
Guido Reifenberger Germany
Hiroko Ohgaki France
David W. Ellison United States
Webster K. Cavenee United States
Jill S. Barnholtz‐Sloan United States
David N. Louis United States
Arie Perry relative to Peter C. Burger United States Peter C. Burger's profile →
Citations per field
00.5×6.1×
Peter C. Burger · 1×
Citations per year

Countries citing papers authored by Arie Perry

Since Specialization
Citations

This map shows the geographic impact of Arie Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arie Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arie Perry more than expected).

Fields of papers citing papers by Arie Perry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arie Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arie Perry. The network helps show where Arie Perry may publish in the future.

Co-authors

The 25 scholars most cited alongside Arie Perry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Arie Perry Line = papers co-authored together Arie Perry links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 384 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
Hit paper breakdown →
201611096
2
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
Hit paper breakdown →
20216614
3
Primary brain tumours in adults
Hit paper breakdown →
20181022
4
Alterations of Chromosome Arms 1p and 19q as Predictors of Survival in Oligodendrogliomas, Astrocytomas, and Mixed Oligoastrocytomas
Hit paper breakdown →
2000643
5
cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”
Hit paper breakdown →
2018568
6 1997472
7
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study
Hit paper breakdown →
2015441
8
Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems
Hit paper breakdown →
2012435
9 2006426
10 1999413
11 2011379
12
Overview of the 2022 WHO Classification of Pituitary Tumors
Hit paper breakdown →
2022314
13 2004313
14
cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas
Hit paper breakdown →
2020313
15 1999309
16 2010300
17 2015289
18 2001288
19
Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations.
1995248
20 1998238

About Arie Perry

Arie Perry is a scholar working on Genetics, Neurology, Epidemiology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 384 papers that have together received 41.0k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (175 papers), Meningioma and schwannoma management (102 papers), Neurofibromatosis and Schwannoma Cases (93 papers), Neuroblastoma Research and Treatments (49 papers), Chromatin Remodeling and Cancer (48 papers), Sarcoma Diagnosis and Treatment (38 papers), Brain Metastases and Treatment (24 papers) and Vascular Malformations Diagnosis and Treatment (18 papers). The work is most often cited by research in Genetics (18.5k citations), Neurology (8.5k citations), Cancer Research (5.3k citations), Epidemiology (8.3k citations) and Pulmonary and Respiratory Medicine (5.5k citations). Arie Perry has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Guido Reifenberger, Andreas von Deimling, David N. Louis, David W. Ellison, Hiroko Ohgaki, Dominique Figarella-Branger, Otmar D. Wiestler, Webster K. Cavenee, Paul Kleihues and Pieter Wesseling. Their work appears in journals such as Brain Pathology, Journal of Neuropathology & Experimental Neurology, Neuro-Oncology, Journal of Neuro-Oncology and Acta Neuropathologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact